EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon

Amol D. Gholap, Pankaj R. Khuspe, Sagar R. Pardeshi, Md Jasim Uddin, Ushasi Das, Navnath T. Hatvate, Satish Rojekar, Prabhanjan Giram, Mohammad Khalid, Yahya E. Choonara, Md. Faiyazuddin

Advanced Therapeutics · 2025-04 · 8 (4)

DOI: 10.1002/adtp.202400169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Therapeutics, online erschienen am 18.09.2024. Verfasst von Amol D. Gholap und 10 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Host‐directed therapies (HDTs) have emerged as a promising strategy to combat viral infections by modifying host factors and immune responses to restrict viral replication and improve patient outcomes. This review summarizes the latest advances and future potential of HDTs in antiviral therapy. With developments in genomics and proteomics, new host targets essential for viral replication have been identified. Gene‐editing tools, such as CRISPR‐Cas9, enable precise manipulation of host genes linked to viral processes, paving the way for innovative HDTs. Emerging approaches, including RNA interference and viral interference, further demonstrate the potential to specifically modify host factors to inhibit viral replication. Additionally, probiotics are being explored for their capacity to enhance immune responses and modulate gut microbiota, offering a natural and safe method for boosting antiviral defenses. Despite these advancements, significant challenges remain, particularly in deciphering complex host–virus interactions and ensuring the safety and efficacy of these therapies. Continued research and clinical evaluation are essential to realize the full potential of HDTs. This review provides a comprehensive overview of current HDT strategies, emphasizing their promise in shaping future antiviral interventions.

Zitieren

APA

Gholap, A. D., Khuspe, P. R., Pardeshi, S. R., Uddin, M. J., Das, U., Hatvate, N. T., Rojekar, S., Giram, P., Khalid, M., Choonara, Y. E., & Faiyazuddin, M. (2025). Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon. Advanced Therapeutics, 8(4). https://doi.org/10.1002/adtp.202400169

Vancouver

Gholap AD, Khuspe PR, Pardeshi SR, Uddin MJ, Das U, Hatvate NT, et al. Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon. Advanced Therapeutics. 2025;8(4). doi:10.1002/adtp.202400169

BibTeX
@article{Gholap2025,
  author = {Gholap, Amol D. and Khuspe, Pankaj R. and Pardeshi, Sagar R. and Uddin, Md Jasim and Das, Ushasi and Hatvate, Navnath T. and Rojekar, Satish and Giram, Prabhanjan and Khalid, Mohammad and Choonara, Yahya E. and Faiyazuddin, Md.},
  title = {Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon},
  journal = {Advanced Therapeutics},
  year = {2025},
  volume = {8},
  number = {4},
  doi = {10.1002/adtp.202400169}
}
Kostenlos starten →